Comparison of Short-Term DAPT and Long-Term DAPT on the Prognosis of PCI Patients: A Meta-Analysis of Randomized Controlled Trials

Background: Dual antiplatelet therapy (DAPT) is the primary medication for patients after percutaneous coronary intervention (PCI). However, the best DAPT duration is still controversial. This systematic review and meta-analysis aims to assess the safety and effectiveness of short-term (3–6 months)...

Full description

Bibliographic Details
Main Authors: Jiaxin Yang, Yaodong Ding, Rui Wang, Kexin Wang, Xiaoli Liu, Hua Shen, Yan Sun, Hailong Ge, Zhe Fang
Format: Article
Language:English
Published: IMR Press 2022-09-01
Series:Reviews in Cardiovascular Medicine
Subjects:
Online Access:https://www.imrpress.com/journal/RCM/23/10/10.31083/j.rcm2310326